Clinical Trials Browser

Interventional × camrelizumab × Endocrine × Clear all

NCT06831175 2025-06-03

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

Phase 2 Recruiting

Adrenal Gland Neoplasms, Adrenocortical Carcinoma